ACEGEN:用于药物发现的生成化学剂的强化学习
Albert Bou1,2, Morgan Thomas1, Sebastian Dittert1
1Computational Science Laboratory, Universitat Pompeu Fabra, Barcelona Biomedical Research Park (PRBB), C Dr. Aiguader 88, 08003 Barcelona, Spain.
Journal of chemical information and modeling
|August 2, 2024
概括
ACEGEN是使用强化学习 (RL) 进行生成药物设计的新工具包. 它简化了复杂的RL算法,提供了与分子优化现有方法相比的或更好的性能.
科学领域:
- 计算化学是一种计算化学.
- 机器学习在药物发现中的作用
背景情况:
- 强化学习 (RL) 在药物设计中显示出分子优化的前景.
- 在平衡RL能力,灵活性,可靠性和效率方面存在挑战.
- 先进的RL算法的复杂性和对专业代码的依赖阻碍了采用.
研究的目的:
- 介绍ACEGEN,一个简化工具包用于生成药物设计.
- 杆TorchRL用于坚固和可重复使用的部件.
- 将ACEGEN的性能与现有的生成建模算法进行验证.
主要方法:
- 使用 TorchRL 库开发了 ACEGEN.
- 将ACEGEN与已发表的生成建模算法进行比较.
- 将ACEGEN应用于多种药物发现案例研究.
主要成果:
- 在生成性药物设计中,ACEGEN表现出同等或更好的性能.
- 该工具包简化了用于分子优化先进RL的应用.
- 在各种药物发现场景中成功应用.
结论:
- ACEGEN为生成性药物设计提供了一个全面而高效的解决方案.
- 该工具包促进了RL在药物发现管道中的使用.
- ACEGEN是开源的,可用于更广泛的研究用途.
相关概念视频
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Structure-Activity Relationships and Drug Design
689
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
689
Principles of Drug Action
5.9K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.9K
Effects of Chemicals: Overview
1.2K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.2K
Preparation of 1° Amines: Gabriel Synthesis
3.5K
Direct alkylation is not a suitable method for synthesizing amines because it produces polyalkylated products. Gabriel synthesis is the most preferred method to exclusively make primary amines. The method uses phthalimide, which contains a protected form of nitrogen that participates in alkylation only once to predominantly give primary amines.
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
3.5K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K


